Product
Bmab
Aliases
Bmab 1000
2 clinical trials
2 indications
Indication
Healthy Control ParticipantsIndication
Postmenopausal Women With OsteoporosisClinical trial
A Randomized, Double-blind, Two-arm, Single-dose, Parallel-Group Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Bmab 1000 and Prolia® in Normal Healthy VolunteersStatus: Completed, Estimated PCD: 2023-10-06
Clinical trial
A Randomized, Double-Blind, Multicenter, Parallel-Arm Phase 3 Study to Compare the Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmenopausal Women With OsteoporosisStatus: Active (not recruiting), Estimated PCD: 2024-06-20